Claims
- 1. An isolated acylase enzyme, wherein the acylase enzyme obtained from Oidiodendron sp. No. 30084 (FERM BP-5943), wherein the acylase catalyzes deacylation of the acyl group R.sup.1 of a cyclic lipopeptide compound of the following general formula (I): ##STR6## wherein R.sup.1 is acyl;
- R.sup.2 is hydroxy or acyloxy;
- R.sup.3 is hydrogen or hydroxy;
- R.sup.4 is hydrogen or hydroxy;
- R.sup.5 is hydrogen or hyroxysulfonyloxy; and
- R.sup.6 is hydrogen or carbamoyl
- or a salt thereof, to give a cyclic peptide of the following general formula (II): ##STR7## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are the same groups as respectively defined above or a salt thereof: wherein the optimum pH for deacylation is from 2 to 4: the optimum temperature for deacylation is from 25 to 45.degree. C.; the enzyme activity is activated in a concentration dependent manner in the presence of methanol up to 20% by volume in the reaction mixture and the enzyme activity is inhibited at concentrations of methanol over 40% by volume.
- 2. A process for producing a cyclic-peptide compound or a salt thereof comprising contacting a cyclic lipopeptide compound or a salt thereof with the acylase enzyme of claim 1, in which the acylase enzyme deacetylates the fatty acyl moiety of a cyclic lipopeptide compound.
- 3. The process of claim 2, wherein the cyclic peptide compound is of the following formula (II): ##STR8## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are the same groups as respectively defined below or a salt thereof, which comprises contacting a cyclic lipopeptide compound of the following general formula (I): ##STR9## wherein R.sup.1 is acyl;
- R.sup.2 is hydroxy or acyloxy;
- R.sup.3 is hydrogen or hydroxy;
- R.sup.4 is hydrogen or hydroxy;
- R.sup.5 is hydrogen or hydroxysulfonyloxy; and
- R.sup.6 is hydrogen or carbamoyl
- or a salt thereof.
- 4. The acylase of claim 1, wherein the enzyme has a molecular weight of 150 kDa, as determined by gel filtration-HPLC.
- 5. The acylase of claim 1, wherein the deacylation Km is 1590 .mu.m and the Vmax is 4.2 U/mg protein, as measured with the cyclic lipopeptide FR901379, at a temperature of 40.degree. C., a pH of 3, and a time of 15 minutes.
- 6. The acylase of claim 1, wherein the level of deacylation of the cyclic lipopeptide FR901379 is greater than the level of acylation of Echinocandin B and Aculeacin A.
- 7. The acylase compound of claim 1, wherein the cyclic lipopeptide is FR901379 or a FR901379 analog thereof.
- 8. The acylase of claim 7, wherein the cyclic lipopeptide analog is Echinocandin B or Aculeacin A.
- 9. The acylase of claim 3, wherein the cyclic lipopeptide is FR901379 or FR901379 analogs.
- 10. The acylase of claim 9, wherein the cyclic lipopeptide analog is Echinocandin B or Aculeacin A.
- 11. The acylase enzyme of claim 1, wherein
- R.sup.5 is hydroxysulfonyloxy, and
- R.sup.6 is carbamoyl.
- 12. The process of claim 2, wherein
- R.sup.5 is hydroxysulfonyloxy, and
- R.sup.6 is carbamoyl.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8/151948 |
Jun 1996 |
JPX |
|
Parent Case Info
This application is a 371 of PCT/JP97/02003 filed Jun. 11, 1997.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP97/02003 |
6/11/1997 |
|
|
12/31/1998 |
12/31/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/47738 |
12/18/1997 |
|
|
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
H1638 |
Furuta et al. |
Mar 1997 |
|
5376634 |
Uwamoto et al. |
Dec 1994 |
|
5618787 |
Jamison et al. |
Apr 1997 |
|
5629289 |
Rodriguez |
Dec 1994 |
|
Non-Patent Literature Citations (1)
Entry |
Computer Derwent Dgene Abstract 1997P-W45450 Peptide WO 9732975 New Cyclic Lipo:Peptide Acylase, Sep. 12, 1997. |